septomonab
mAbexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Lipopolysaccharide (LPS)INHIBITOR
Lipopolysaccharide (LPS) inhibitor
- Lipopolysaccharide (LPS)Immunity, passive
Lipopolysaccharide (LPS) immunity, passive
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Multi-specific
- No
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL2109181 ↗
Also known as
- centoxin
- centoxin
- ha-1a
- ha-1a monoclonal antibody
- nebacumab
- nebacumab
- septomonab
- septomonab